Unlock this StockReport nowClick to Unlock

3D Signatures Inc Share Price

DXD C$0.045 0.0  0.0%

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 30th Jun 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue C$m
Operating Profit C$m
Net Profit C$m
EPS Reported C$
EPS Normalised C$
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps C$
Capex ps C$
Free Cashflow ps C$
Last ex-div: 30th Aug, paid: 30th Aug more... Dividends
Dividend ps C$
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc C$m
Working Capital C$m
Net Fixed Assets C$m
Net Debt C$m
Book Value C$m
Average Shares m
Book Value ps C$

FINANCIAL BRIEF: For the three months ended 30 September 2018, 3D Signatures Inc revenues was not reported. Net loss decreased 46% to C$579K. Lower net loss reflects Research and development decrease of 81% to C$71K (expense), Selling/General/Admin. Expense decrease of 27% to C$508K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.02 to -C$0.01. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 30th Sep '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
30th Jun 2019
30th Jun 2020

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a () () () () () ()
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for 3D Signatures Inc
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
There are no named brokers.

Profile Summary

3D Signatures Inc, formerly Plicit Capital Corp, is a Canada-based personalized medicine company with a software platform based on the three-dimensional (3D) analysis of telomere organization. Its software-based technology and prognostic methodology targets various diseases that demonstrate genomic instability, including cancer and neurological disorders. It is engaged in developing over five diagnostic and prognostic products for cancers and neurological disorders, including 3D Telo-PC, 3D Telo-RS, 3D Telo-MM, 3D Telo-BC, 3D Telo-LC and 3D Telo-AD. Its 3D Telo-PC enables clinicians to identify patient stability during diagnosis, optimize treatment plans and manage monitoring with a non-invasive blood test. The 3D Telo-RS allows clinicians to identify high-risk patients during diagnosis and optimize treatment plans. Its technology analyzes a specific part of an individual’s deoxyribonucleic acid to determine how a disease will progress and if a patient will respond to treatment.

Directors: Hugh Rogers (CHM) , Ryan Cheung (CFO) , Kevin Little (CSO) , Sabine Mai (DRC) , Ferenc Somogyvari (DRC) , Jeffery Poloni (IND) , Jevin Werbes (IND) 34,

No. of Employees: n/a No. of Shareholders: n/a

Last Annual June 30th, 2018
Last Interim September 30th, 2018
Incorporated May 25, 2011
Public Since February 15, 2012
Shares in Issue 66,531,545
Free Float 32.8m (49.3%)
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange TSX Venture Exchange
Eligible for an ISA? a SIPP?

DXD Share Price Performance DXD Share Price Quote
0.0  0.0%
Traded 5:37pm · Minimum 15 min delayed · NMS:

Latest DXD News Announcements (delayed)

Upcoming DXD Events

Recent ↓
Friday 1st June, 2018 (estimate)
Q3 2018 3D Signatures Inc Earnings Release
Thursday 1st March, 2018
Q2 2018 3D Signatures Inc Earnings Release
Wednesday 29th November, 2017
Q1 2018 3D Signatures Inc Earnings Release
Tuesday 24th October, 2017
Q4 2017 3D Signatures Inc Earnings Release
Wednesday 31st May, 2017
Q3 2017 3D Signatures Inc Earnings Release
Thursday 2nd March, 2017
Q2 2017 3D Signatures Inc Earnings Release
Tuesday 30th August, 2016
Plicit Capital Corp Reverse Split For PLP.H.V
Wednesday 24th August, 2016
Plicit Capital Corp Secondary Public Offering Pricing

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.

Should you buy DXD

Access DXD Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis